This inventor holds 5 USPTO granted patents. Top assignees: Guardant Health, Inc., Other. Active years: 1999-2023.
Location History:
- 1233 Bernex, CH (1999)
- CH-1203 Geneva, CH (2007)
- Geneva, CH (2010 - 2023)
Company Filing History:
2 out of 150 
3 out of 834,350 Years Active: 1999-2023
Title: Philippe Anker: Innovator in Cancer Detection
Introduction
Philippe Anker is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of cancer detection, holding a total of 5 patents. His work focuses on innovative methods that enhance the diagnosis and monitoring of cancer.
Latest Patents
One of Philippe Anker's latest patents is a method for the detection of cancer. This invention relates to diagnosing and monitoring the evolution of cancer by analyzing and quantifying overexpressed and amplified genes in the plasma or serum of cancer patients. The method involves a comprehensive analysis of both DNA and RNA from specific genes, which reflect gene amplification and overexpression compared to healthy controls.
Career Highlights
Throughout his career, Philippe Anker has worked with various companies, including Guardant Health, Inc. His expertise in cancer detection has positioned him as a key figure in the medical research community.
Collaborations
Philippe Anker has collaborated with notable individuals in his field, including Maurice Stroun and Valeri I Vasioukhin. These collaborations have furthered his research and innovations in cancer detection.
Conclusion
Philippe Anker's contributions to cancer detection through his innovative patents highlight his commitment to advancing medical science. His work continues to impact the field positively, offering new methods for diagnosing and monitoring cancer.